您当前的位置:
首页 >
文章列表页 >
Study on Main Changes of Counterfeit and Inferior Drugs ’Relevant Provisions in the Newly Revised Drug Administration Law and Their Impact on Law Enforcement
更新时间:2022-06-21
    • Study on Main Changes of Counterfeit and Inferior Drugs ’Relevant Provisions in the Newly Revised Drug Administration Law and Their Impact on Law Enforcement

    • China Pharmacy   Vol. 31, Issue 17, (2020)
    • Published:2020,

    扫 描 看 全 文

  • LIANG Yun, SHAO Rong. Study on Main Changes of Counterfeit and Inferior Drugs ’Relevant Provisions in the Newly Revised Drug Administration Law and Their Impact on Law Enforcement. [J]. China Pharmacy 31(17).(2020) DOI:

  •  
  •  

0

Views

18

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Analysis and enlightenment of drug-related administrative penalty cases in medical institutions from 2020 to 2022
Analysis of influential factors for potentially inappropriate medication in elderly cancer patients
高危药品分级管理模式探讨
我院医院信息系统的改进及合理用药监控软件的应用
浅析我国农村用药安全现状、存在的问题与对策

Related Author

LIU Wei
XIAO Haoxiang
CAO Linlin
QIAN Yating
YUE Zhongsheng
WANG Huiling
WANG Junping
HUANG Lingling

Related Institution

School of Pharmacy, Zhengzhou Railway Vocational & Technical College
College of Pharmacy, Zhengzhou University
Henan Provincial Drug Evaluation and Inspection Center
Center of Pharmacy, Hefei Cancer Hospital, Chinese Academy of Sciences
Dept. of Gastrointestinal Surgery, Hefei Cancer Hospital, Chinese Academy of Sciences
0